🚨Pre-print alert: Here, we show that CAR-T *and* CAR-NK persistence is negatively self-regulated through activation dependent FAS ligand expression. Further highlights FAS as an actionable molecule to enhance cell therapies. Parker Institute for Cancer Immunotherapy Memorial Sloan Kettering Cancer Center biorxiv.org/content/10.110…

What is the "Holy Grail" of tumor antigens❓ Found out in our lab's recent interview with The Scientist (The Scientist )👇. Memorial Sloan Kettering Cancer Center Parker Institute for Cancer Immunotherapy #Tcellpower the-scientist.com/a-quest-for-th…

Excited to see our phase 2 multicenter study of Tumor-Infiltrating Lymphocyte in Advanced #LungCancer Resistant to Immunotherapy in Cancer Discovery. #TIL #Celltherapy aacrjournals.org/cancerdiscover…

So proud! Immense gratitude to Chris and the rest of the Klebanoff_Lab for such fantastic mentorship, to Conquer Cancer, the ASCO Foundation for 💸💸💸 to support us, and all cancer patients HopeForStomachCancer and beyond, whose contributions are central to how we discover novel T cell therapies⬇️⬇️⬇️